Dialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising a ₹353.4 crore fresh issue and 1.27 crore shares OFS. Proceeds will fund new dialysis centres, debt repayment, and corporate needs.
South Korea’s KOSPI drops 7% as global chipmaker selloff deepens
South Korean stocks experienced a significant decline on Tuesday. This downturn was driven by a global selloff in chipmakers and rising competition from China. SK